Release from polymeric prodrugs: linkages and their degradation.

Polymeric prodrugs have evolved into a very useful class of drug delivery agents. Numerous polymeric prodrugs have been prepared for applications ranging from passive drug targeting to controlled release. The mechanistic aspects of the release processes, however, have not been clearly delineated. This review highlights the salient features of the chemical reactions that are responsible for drug release from these systems. The mechanisms of release from polymeric prodrugs employing various chemical linkages, esters, carbonates, carbamates, C=N linkage and amides, are discussed.

[1]  R. Borchardt,et al.  Prodrug strategies based on intramolecular cyclization reactions. , 1997, Journal of pharmaceutical sciences.

[2]  R. Duncan.  Polymer-Drug Conjugates: Targeting Cancer , 2002 .

[3]  P Buchwald,et al.  Structure-metabolism relationships: steric effects and the enzymatic hydrolysis of carboxylic esters. , 2001, Mini reviews in medicinal chemistry.

[4]  A. J. Kirby,et al.  Structure and efficiency in intramolecular and enzymic catalysis. Catalysis of amide hydrolysis by the carboxy-group of substituted maleamic acids , 1972 .

[5]  E. A. Bekturov,et al.  Synthetic water-soluble polymers in solution , 1986 .

[6]  C. G. Pitt,et al.  Manipulation of the rate of hydrolysis of polymer-drug conjugates: The secondary structure of the polymer , 1996 .

[7]  C. Larsen,et al.  Macromolecular Prodrugs. XVI. Colon-Targeted Delivery—Comparison of the Rate of Release of Naproxen from Dextran Ester Prodrugs in Homogenates of Various Segments of the Pig Gastrointestinal (GI) Tract , 1989, Pharmaceutical Research.

[8]  K. Krisch,et al.  [Carboxylesterases from beef liver microsomes, II. Dissociation and association, molecular weight, reaction with E 600]. , 1967, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[9]  Wim E. Hennink,et al.  Degradation and release behavior of dextran-based hydrogels , 1997 .

[10]  Ashutosh Chilkoti,et al.  Targeted drug delivery by thermally responsive polymers. , 2002, Advanced drug delivery reviews.

[11]  K. Ulbrich,et al.  Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymers , 1991 .

[12]  R. Mashelkar,et al.  Pendent chain linked delivery systems: II. Facile hydrolysis through molecular imprinting effects , 1997 .

[13]  D. Kerr,et al.  Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Y. Ikada,et al.  Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. , 1994, Journal of pharmaceutical sciences.

[15]  J. Sussman,et al.  Relationship between sequence conservation and three‐dimensional structure in a large family of esterases, lipases, and related proteins , 1993, Protein science : a publication of the Protein Society.

[16]  A. Schindler,et al.  The kinetics of drug cleavage and release from matrices containing covalent polymer-drug conjugates , 1995 .

[17]  M. Royzen,et al.  Anticancer drug delivery systems: N4-acyl poly(ethyleneglycol) prodrugs of ara-C. I. Efficacy in solid tumors. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[18]  F. Horkay,et al.  Tailoring the swelling pressure of degrading dextran hydroxyethyl methacrylate hydrogels. , 2003, Biomacromolecules.

[19]  J. Kopeček.  Controlled biodegradability of polymers--a key to drug delivery systems. , 1984, Biomaterials.

[20]  E. Hoffmann,et al.  Kinetics of Hydrolysis of Hydroxy and Methoxy Derivatives of N-Benzylidene-2-aminopropane , 1966 .

[21]  L. Dittert,et al.  Acetaminophen prodrugs. 3. Hydrolysis of carbonate and carboxylic acid esters in aqueous buffers. , 1970, Journal of pharmaceutical sciences.

[22]  C. Meares,et al.  Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial library. , 1998, Bioconjugate chemistry.

[23]  K. Ulbrich,et al.  Synthesis of Biodegradable Polymers for Controlled Drug Release a , 1997, Annals of the New York Academy of Sciences.

[24]  E. Schacht,et al.  Synthesis of polyglutamine and dextran conjugates of streptomycin with an acid-sensitive drug-carrier linkage. , 1996 .

[25]  S. Furukawa,et al.  Synthesis of water-soluble polymeric prodrugs possessing 4-methylcatechol derivatives by mechanochemical solid-state copolymerization and nature of drug release. , 2002, Chemical & pharmaceutical bulletin.

[26]  C. McCormick,et al.  Synthesis, Characterization, and Release Mechanisms of Polymers Containing Pendant Herbicides , 1977 .

[27]  J. Cassidy,et al.  The place of polymer prodrugs in cancer therapy , 2000 .

[28]  J. Keana,et al.  Molecular amplifiers: synthesis and functionalization of a poly(aminopropyl)dextran bearing a uniquely reactive terminus for univalent attachment to biomolecules. , 1992, Bioconjugate chemistry.

[29]  J. Kopecek,et al.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. , 1987, British Journal of Cancer.

[30]  S. Brocchini,et al.  Competitive Reactions During Amine Addition to cis-Aconityl Anhydride , 2002 .

[31]  Glen S. Kwon,et al.  Methotrexate Esters of Poly(Ethylene Oxide)-Block-Poly(2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release , 2000, Pharmaceutical Research.

[32]  H. Ringsdorf,et al.  Effect of molecular size of 125I-labelled poly(vinylpyrrolidone) on its pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages. , 1981, The Biochemical journal.

[33]  Jan Feijen,et al.  Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers , 1993 .

[34]  Zheng-Rong Lu,et al.  Design of novel bioconjugates for targeted drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Jean Campbell,et al.  Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs. , 2003, Bioconjugate chemistry.

[36]  K. Ulbrich,et al.  HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[37]  R. Mülhaupt,et al.  Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. , 1999, Bioorganic & medicinal chemistry.

[38]  K. Ulbrich,et al.  Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of methotrexate: Synthesis and in vitro drug release , 1997 .

[39]  K. Ulbrich,et al.  Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studies. , 1993, Journal of drug targeting.

[40]  N. Bodor,et al.  Structure-based estimation of enzymatic hydrolysis rates and its application in computer-aided retrometabolic drug design. , 2000, Die Pharmazie.

[41]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[42]  C. Larsen,et al.  Macromolecular prodrugs I. Kinetics and mechanism of hydrolysis of O-benzoyl dextran conjugates in aqueous buffer and in human plasma , 1985 .

[43]  Chun Xing Li.  Poly(L-glutamic acid)--anticancer drug conjugates. , 2002, Advanced drug delivery reviews.

[44]  R. Mashelkar,et al.  Pendent chain linked delivery systems: I facile hydrolysis through anchimeric effect , 1996 .

[45]  J. Kopeček,et al.  Degradation of side-chains ofN-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases , 1982, Bioscience reports.

[46]  J. Collins,et al.  Structure‐based subsite specificity mapping of human cathepsin D using statine‐based inhibitors , 1997, Protein science : a publication of the Protein Society.

[47]  K. Petrak,et al.  Transport of macromolecules across the capillary walls , 1989 .

[48]  Bonnie F. Sloane,et al.  Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.

[49]  J. Kopeček,et al.  Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. , 1987, Journal of biomedical materials research.

[50]  Y. Chow,et al.  Intramolecular Catalysis of Hydrolytic Reactions. II. The Hydrolysis of Phthalamic Acid1,2 , 1958 .

[51]  K. Zhu,et al.  Blends of PVA and PGLA: control of the permeability and degradability of hydrogels by blending , 1992 .

[52]  C. Larsen.  Macromolecular prodrugs. XII. Kinetics of release of naproxen from various polysaccharide ester prodrugs in neutral and alkaline solution , 1989 .

[53]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[54]  T. Park,et al.  Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[55]  L. G. Donaruma.  Synthetic biologically active polymers , 1975 .

[56]  K. Ulbrich,et al.  Synthesis of HPMA Copolymers Containing Doxorubicin Bound via a Hydrazone Linkage. Effect of Spacer on Drug Release and in vitro Cytotoxicity , 2002 .

[57]  K. Krisch,et al.  [Carboxylesterases from beef liver microsomes. I. Isolation, properties and substrate specificity]. , 1967, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[58]  Zheng-Rong Lu,et al.  Influence of the Structure of Drug Moieties on the in Vitro Efficacy of HPMA Copolymer–Geldanamycin Derivative Conjugates , 2002, Pharmaceutical Research.

[59]  J. Kopeček,et al.  Degradation of side chains of N-(2-hydroxypropyl) methacrylamide copolymers by lysosomal enzymes. , 1980, Biochemical and biophysical research communications.

[60]  E. Schacht,et al.  Polymeric prodrugs of 5-fluorouracil , 1997 .

[61]  H. Zhao,et al.  Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds. , 1999, Journal of medicinal chemistry.

[62]  K. Ulbrich,et al.  Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[63]  C. Longley,et al.  Utility of poly(ethylene glycol) conjugation to create prodrugs of amphotericin B. , 2003, Bioconjugate chemistry.

[64]  Z. Lu,et al.  Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers. , 2001, Bioconjugate chemistry.

[65]  Richard B Greenwald,et al.  Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.

[66]  R. Schowen,et al.  Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Jindřich Kopeček,et al.  Polymers containing enzymatically degradable bonds, 8. Degradation of oligopeptide sequences in N‐(2‐hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B , 1983 .

[68]  M Hosokawa,et al.  The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.

[69]  Yokoyama Masayuki,et al.  Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer , 1990 .

[70]  F. Kratz,et al.  Drug-polymer conjugates containing acid-cleavable bonds. , 1999, Critical reviews in therapeutic drug carrier systems.

[71]  H. Chiang,et al.  Synthesis and properties of a naproxen polymeric prodrug , 2002, The Journal of pharmacy and pharmacology.

[72]  M. Yokoyama.  Drug Targeting with Polymeric Micelle Drug Carriers , 2002 .

[73]  F. Veronese,et al.  Bioconjugation in pharmaceutical chemistry. , 1999, Farmaco.

[74]  J. Schug,et al.  Correlation of nonadditive kinetic effects with molecular geometries. Structure and reactivity of alkyl- and cycloalkenylpyridines , 1984 .

[75]  J. Kopeček,et al.  Polymers containing enzymatically degradable bonds, 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes† , 1983 .

[76]  H. Maeda,et al.  Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. , 2003, Advances in experimental medicine and biology.

[77]  R. S. Brown.  Studies in Amide Hydrolysis: Acid, Base, and Water Reactions , 2000 .

[78]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[79]  T. Park,et al.  Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release , 1999, Pharmaceutical Research.

[80]  Hans Bundgaard,et al.  Design of prodrugs , 1985 .

[81]  R. M. Fitch,et al.  Controlled release of pendant bioactive materials from acrylic polymer colloids , 1986 .

[82]  C. Larsen,et al.  Macromolecular prodrugs. IV: Kinetics of hydrolysis of metronidazole monosuccinate dextran ester conjugates in aqueous solution and in plasma ― sequential release of metronidazole from the conjugates at physiological pH , 1987 .

[83]  K. Ulbrich,et al.  Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo , 1992 .

[84]  R. Duncan,et al.  Synthesis, controlled release properties and antitumour activity of alginate-cis-aconityl-daunomycin conjugates , 1995 .

[85]  W. Rutter,et al.  Role of the S' subsites in serine protease catalysis. Active-site mapping of rat chymotrypsin, rat trypsin, alpha-lytic protease, and cercarial protease from Schistosoma mansoni. , 1994, Biochemistry.

[86]  K. Breddam,et al.  Interdependency of the binding subsites in subtilisin. , 1992, Biochemistry.

[87]  P. Dettmar,et al.  Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[88]  J. Kopeček,et al.  Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. , 1985, Biomaterials.

[89]  W. Shen,et al.  cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. , 1981, Biochemical and biophysical research communications.

[90]  M. Tuttle,et al.  Controlled release of water-soluble macromolecules from bioerodible hydrogels. , 1983, Biomaterials.

[91]  H. G. Schild.  Poly(N-isopropylacrylamide): experiment, theory and application , 1992 .

[92]  E. Schacht,et al.  EVALUATION OF THE HYDROLYTIC AND ENZYMATIC STABILITY OF MACROMOLECULAR MITOMYCIN-C DERIVATIVES. , 1994 .

[93]  K. Zhu,et al.  Controlled Delivery System for Norethindrone Based on Biodegradable Poly- α, β -(Hydroxyalkyl)-DL-Aspartamide , 2002 .

[94]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[95]  前田 浩.  Polymer drugs in the clinical stage : advantages and prospects , 2003 .

[96]  E. Schacht,et al.  The crucial role of spacer groups in macromolecular prodrug design , 1996 .

[97]  E. Schacht,et al.  Macromolecular derivatives of N,N-di-(2-chloroethyl)-4-phenylene diamine mustard. 2. In vitro cytotoxicity and in vivo anticancer efficacy. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[98]  R. Mehvar,et al.  Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. , 1992, Journal of pharmaceutical sciences.

[99]  N. Bodor,et al.  Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters. , 2002, Die Pharmazie.